New antibiotic discovered in lungs of cystic fibrosis patient

Researchers have discovered a new antibiotic in the lungs of a cystic fibrosis patient that may prove effective in the fight against antibiotic-resistant tuberculosis, according to a study published in the Journal of the American Chemical Society.

The study details the discovery of a species of Burkholderia gladioli isolated from the saliva and mucus of a pediatric cystic fibrosis patient. The bacterium produces an antibiotic called gladiolin, which was found to be active against multiple isolates of drug-resistant strains of TB in the laboratory setting.

"Overall, these data suggest that gladiolin may represent a useful starting point for the development of novel drugs to tackle multidrug-resistant TB," wrote the study's authors.

To learn more about drug-resistant TB, click here

More articles on infection control: 
Chronic Lyme disease treatments put patients at risk for serious harm, says CDC  
The Joint Commission releases compendium of VTE care resources 
CRE endemic across DC healthcare facilities, study suggests

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars